Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Esmolol on the Hemodynamic Response to Orotracheal Extubation: a Prospective, Randomized, Double-blind and Placebo-controlled Trial

NCT04264286 is registered in ClinicalTrials.gov with Hospital de Base as lead sponsor.

NCT NCT04264286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Esmolol on the Hemodynamic Response to Orotracheal Extubation: a Prospective, Randomized, Double-blind and Placebo-controlled Trial
Lead sponsor
Hospital de Base
Phase
Phase 4
Overall status
Unknown status
Start date
July 1, 2019
Completion date
July 31, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta blocker, hemodynamic instability